Cite Filings / HOWL / 0001785530-26-000012

Feed Companies Filings Check

Sign in

10-Q

Quarterly Report

Werewolf Therapeutics, Inc. Filed 2026-05-07 Acc 0001785530-26-000012

Documents 1

10-Q Quarterly Report , howl-20260331.htm

Around this filing

2026-07-31 10-Q Quarterly Report
2026-05-07 10-Q Quarterly Report
2026-05-07 8-K Results of operations
2026-05-07 4 Director sold 100,581 shares at an average $0.64 ($64,217)
2026-05-05 SCHEDULE 13D/A Beneficial Ownership Report
2026-05-04 4 Director sold 274,619 shares at an average $0.72 ($198,310)
2025-11-04 10-Q Quarterly Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading howl-20260331.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…